Impact of TRIPS in India: An Access to Medicines Perspective examines the effects of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on India's pharmaceutical sector and access to medicines. The book analyzes how changes in patent laws have influenced drug prices, pharmaceutical innovation, foreign investment, and the availability of affordable medicines.

The author evaluates India's transition to a TRIPS-compliant patent regime and discusses issues such as pharmaceutical patents, generic medicines, price controls, health insurance, and healthcare accessibility. A major focus of the book is the challenge of balancing intellectual property protection with public health needs in developing countries.

The work also proposes policy measures and healthcare models aimed at extending access to medicines to the broader population and assesses whether the TRIPS framework is appropriate for developing economies.